Q: How about biologics? Are there concerns with using them in IBD? Pyrsopoulos: Biologics are often used to treat moderate-to-severe disease states in IBD.

A substantial number of patients with inflammatory bowel disease rely on cannabis and CBD oil for symptom relief, indicating a need for more rigorous investigation, according to a study published in ...

SAN DIEGO -- Biomarker-informed therapy guidance improved disease control rates among patients with inflammatory bowel disease (IBD) compared with standard best care, a randomized trial showed.

The marketplace introduction of infliximab for the treatment of IBD did not reduce hospitalization or surgery rates in a large population of patients with Crohn disease and ulcerative colitis.

About 3 million Americans are living with the pain of inflammatory bowel disease.

Drugs currently in clinical trials for other conditions could help reduce risk of heart attack and stroke for IBD patients.